Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation

Middle east respiratory syndrome coronavirus (MERS-CoV) is a fatal pathogen that poses a serious health risk worldwide and especially in the middle east countries. Targeting the MERS-CoV 3-chymotrypsin-like cysteine protease (3CL(pro)) with small covalent inhibitors is a significant approach to inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamri, Mubarak A., Tahir ul Qamar, Muhammad, Afzal, Obaid, Alabbas, Alhumaidi B., Riadi, Yassine, Alqahtani, Safar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040153/
https://www.ncbi.nlm.nih.gov/pubmed/33867606
http://dx.doi.org/10.1016/j.molliq.2021.115699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040153/
https://www.ncbi.nlm.nih.gov/pubmed/33867606
http://dx.doi.org/10.1016/j.molliq.2021.115699

Ejemplares similares